102 related articles for article (PubMed ID: 28529643)
21. LentiRILES, a miRNA-ON sensor system for monitoring the functionality of miRNA in cancer biology and therapy.
Simion V; Loussouarn C; Laurent Y; Roncali L; Gosset D; Reverchon F; Rousseau A; Martin F; Midoux P; Pichon C; Garcion E; Baril P
RNA Biol; 2021 Oct; 18(sup1):198-214. PubMed ID: 34570661
[TBL] [Abstract][Full Text] [Related]
22. MiR-200c-3p increased HDMEC proliferation through the notch signaling pathway.
Hu X; Bai S; Li L; Tian P; Wang S; Zhang N; Shen B; Du J; Liu S
Exp Biol Med (Maywood); 2021 Apr; 246(8):897-905. PubMed ID: 33472424
[TBL] [Abstract][Full Text] [Related]
23. Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.
Wang M; Jiang X; Yang Y; Chen H; Zhang C; Xu H; Qi B; Yao C; Xia H
Neurotherapeutics; 2020 Oct; 17(4):2028-2040. PubMed ID: 32822001
[TBL] [Abstract][Full Text] [Related]
24. Dexmedetomidine attenuates cisplatin-induced cognitive impairment by modulating miR-429-3p expression in rats.
Li C; Niu J; Zhou B; Deng W; Deng F; Zhou Z; Xu G
3 Biotech; 2020 Jun; 10(6):244. PubMed ID: 32411568
[TBL] [Abstract][Full Text] [Related]
25. Interfering MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer.
Qin Y; Chen W; Jiang G; Zhou L; Yang X; Li H; He X; Wang HL; Zhou YB; Huang S; Liu S
Sci Adv; 2020 Feb; 6(8):eaaw9960. PubMed ID: 32128390
[TBL] [Abstract][Full Text] [Related]
26. LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis.
Li B; Zhao H; Song J; Wang F; Chen M
Hum Cell; 2020 Jan; 33(1):159-174. PubMed ID: 31713817
[TBL] [Abstract][Full Text] [Related]
27. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
28. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2.
Xu CY; Dong JF; Chen ZQ; Ding GS; Fu ZR
Cancer Control; 2019; 26(1):1073274819846593. PubMed ID: 31046434
[TBL] [Abstract][Full Text] [Related]
29. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
[TBL] [Abstract][Full Text] [Related]
30. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
[TBL] [Abstract][Full Text] [Related]
31. The miR-200 family: multiple effects on gliomas.
Peng L; Fu J; Ming Y
Cancer Manag Res; 2018; 10():1987-1992. PubMed ID: 30034253
[TBL] [Abstract][Full Text] [Related]
32. Computational identification of specific genes for glioblastoma stem-like cells identity.
Fiscon G; Conte F; Licursi V; Nasi S; Paci P
Sci Rep; 2018 May; 8(1):7769. PubMed ID: 29773872
[TBL] [Abstract][Full Text] [Related]
33. Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer.
Liu H; Lei C; He Q; Pan Z; Xiao D; Tao Y
Mol Cancer; 2018 Feb; 17(1):64. PubMed ID: 29471827
[TBL] [Abstract][Full Text] [Related]
34. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
35. MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin.
Qin Y; Chen W; Liu B; Zhou L; Deng L; Niu W; Bao D; Cheng C; Li D; Liu S; Niu C
Theranostics; 2017; 7(6):1663-1673. PubMed ID: 28529643
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
[TBL] [Abstract][Full Text] [Related]
37. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
[TBL] [Abstract][Full Text] [Related]
38. MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.
Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
Am J Cancer Res; 2017; 7(8):1738-1753. PubMed ID: 28861329
[TBL] [Abstract][Full Text] [Related]
39. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.
He J; Zhang W; Zhou Q; Zhao T; Song Y; Chai L; Li Y
Int J Biochem Cell Biol; 2013 Sep; 45(9):1962-73. PubMed ID: 23811124
[TBL] [Abstract][Full Text] [Related]
40. The role of microRNAs in COVID-19 with a focus on miR-200c.
Sodagar H; Alipour S; Hassani S; Aziz SG; Ansari MHK; Asghari R
J Circ Biomark; 2022; 11():14-23. PubMed ID: 35356072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
